|
SIGY Sigyn Therapeutics Inc 1642159 |
| Income Statement |
|
Net Income
|
2025-09-30
|
$-578,503.00 |
| Balance Sheet |
|
Current Assets
|
$85,571.00 |
|
Assets
|
$135,571.00 |
|
Current Liabilities
|
$3,989,491.00 |
|
Liabilities
|
$6,052,780.00 |
|
Equity
|
$-5,917,209.00 |
|
Shares Out
|
1605377.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-646,208.00 |
| Market Analysis |
Market Cap
|
$32,107.54 |
|
Price
|
$0.03 |
|
PB
|
7.90 |
|
EPS
|
-0.36 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:49 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:50 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SIGY documents filed with the SEC.
SIGY Filings
Clear
